pain drug

positive negative up down good bad mixed

Biotech

Vertex's phase 3 pain trials hit goals but fail to beat Vicodin

Vertex’s attempt to crack the blockbuster pain market has delivered a pair of phase 3 wins. And yet, the positive news was tempered by a key failure.

Nick Paul Taylor Jan 30, 2024 8:00am

An artists concept of spinal pain A silhouette of a person stands holding their back The spinal cord is highlighted on the

Drug more effective on pain than gabapentin, minus side effects

Nov 14, 2023 10:00am

Graphic of arrows missing the target

Strike 3: Aptinyx's pain prospect flunks 3rd midphase trial

Aug 12, 2022 8:23am

stop light green

No pain, only gain for Vertex as FDA greenlights phase 3 trial

Jul 22, 2022 10:59am

sun rise sun morning sun clouds sky

Lexicon touts 'wonderful morning' as pain drug clears phase 2

Jun 30, 2022 10:24am

Surgery patient clinical trial hospital surgeon

Vertex gets phase 2 proof-of-concept for non-opioid painkiller

Mar 31, 2022 10:50am